October 2026

Researchers bring on-the-go CCTA scans to underserved communities ()
HeartMate 3 LVAD linked to 16% risk of stroke, other neurological issues—what heart failure specialists should know ()
Workout supplement recalled after FDA finds ‘hidden ingredient’ known to raise blood pressure, cause heart problems ()
Policy expert explains why cardiology services in the US are getting more expensive ()
The world’s best heart hospitals: New list includes many from United States ()
Fewer Americans are dying from heart disease—Black patients still face the highest risks ()
American Heart Association announces late-breaking research for Scientific Sessions 2026 ()
Real-world data highlight the benefits of thrombectomy for pulmonary embolism patients ()
Canon launches new TAVR technology to help structural heart programs meet rising demand ()
Cardiologist performs first US implant of new heart device ()
Extracellular volume assessments can make cardiac CT more valuable than ever ()
FDA-cleared cardiothoracic imaging tools being added to popular AI platform ()
A Practical Guide to Cardiovascular Strategic Planning for Better Care Delivery ()
American Heart Association celebrates high-quality outpatient care ()
CMS considers covering TAVR for aortic regurgitation ()
A big win for Foundayo: GLP-1 pill orforglipron helps patients lose weight, protect their hearts ()
FDA approves updates to Abbott’s CardioMEMS heart failure platform ()
More and more young children now taking GLP-1 drugs for weight loss ()
New heart attack drug submitted to FDA for review ()
American College of Cardiology wants clinicians to feel ‘safe, supported and respected’ ()
Mount Sinai researchers aim to learn more about treating SCAD ()
FDA approves first heart valve that grows with children ()
Renal denervation gains new Category I CPT codes ()
Mouse hearts can regenerate by blocking an energy transfer enzyme ()
Staying ALERT: AI puts spotlight on heart patients with untreated valve disease ()